Evidence map›Paper›PMID 35591364›Full record

ArticleMaterials (Basel, Switzerland)2022

Stereoselective Synthesis and Anticancer Activity of 2,6-Disubstituted

Tomasz Bartosik, Joanna Drogosz-Stachowicz, Anna Janecka, Jacek Kędzia, Barbara Pacholczyk-Sienicka, Jacek Szymański, Katarzyna Gach-Janczak, Tomasz Janecki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tomasz BartosikInstitute of Organic Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.
Joanna Drogosz-StachowiczDepartment of Biomolecular Chemistry, Medical University of Łódź, Mazowiecka 6/8, 92-215 Lodz, Poland.
Anna JaneckaDepartment of Biomolecular Chemistry, Medical University of Łódź, Mazowiecka 6/8, 92-215 Lodz, Poland.
Jacek KędziaInstitute of Organic Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.
Barbara Pacholczyk-SienickaInstitute of Organic Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0001-9767-7429
Jacek SzymańskiCentral Scientific Laboratory, Medical University of Łódź, Mazowiecka 6/8, 92-215 Lodz, Poland.
Katarzyna Gach-JanczakDepartment of Biomolecular Chemistry, Medical University of Łódź, Mazowiecka 6/8, 92-215 Lodz, Poland.
Tomasz JaneckiInstitute of Organic Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.ORCID 0000-0002-4898-1405
Lodz University of Technology · PLMedical University of Lodz · PL

Funding

Lodz University of Technology 501-3-32-1-2Medical University of Lodz 503/1-156-02/503-11-001-19-00
6 · The paper itself

Abstract

In this report, we present efficient and stereoselective syntheses of 2,6-disubstituted

Indexed as

3-methylidenedihydropyran-4-onesapoptosiscell cyclecytotoxic activityHorner–Wadsworth–Emmons olefinationMichael additiontopoisomerase II inhibitors

Identifiers

PMID35591364
PMCPMC9105583
OpenAlexW4224311075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.